Broncus Medical Inc., (HKG: 2216) a provider of lung disease precision intervention solutions with operations in Shanghai, Hangzhou (China), and San Jose, Seattle (United States), is set to fully acquire Fibernova Holding Corporation for a total consideration of USD 2.7 million. The acquisition includes a USD 1.7 million equity exchange payment and a milestone payment of USD 1 million.
Fibernova’s Innovation in Medical Imaging Systems
Fibernova is a company engaged in the development of the first fiber optic navigation and imaging system designed for various catheters or endoscopes in medical applications. This groundbreaking technology aims to provide real-time display of surrounding tissues and organs during surgical procedures, enhancing precision and safety in surgical navigation. The system utilizes Fiber Bragg Grating (FBG) technology, which is poised to meet the market’s demand for advanced surgical navigation tools.
Financial Overview and Acquisition Impact
As of June 30, 2023, Fibernova holds total assets of USD 342,267. The acquisition by Broncus Medical Inc. is expected to bolster the company’s offerings in the field of precision intervention solutions, particularly in the area of fiber optic navigation systems. This strategic move aligns with Broncus Medical’s commitment to advancing medical technology and improving patient outcomes through innovative solutions.-Fineline Info & Tech
